How a new £244-a-year heart failure drug saved a man from needing a transplant
A heart-failure drug that dramatically improves symptoms and helps boost survival has been approved for NHS use – giving new hope to half a million patients. Called dapagliflozin, the daily tablets are already taken by Type 2 diabetics to control blood sugar levels, but the £244-a-year medication will now be offered to those suffering one … Read more